Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance imaging (MRI) enhancement refers to the use of agents or techniques that improve the visibility and contrast of internal body structures during MRI scans. The primary goal is to increase diagnostic accuracy by making certain tissues, abnormalities, or physiological processes more distinguishable on MR images. This is most commonly achieved through the administration of MRI contrast agents, primarily gadolinium(III) chelates, which alter the relaxation times (primarily T1 and sometimes T2) of nearby water protons in tissues. Recent research focuses on safer GBCAs, targeted molecular probes, and deep learning algorithms to enhance image quality.
Shortening T1 and T2 relaxation times of water protons in tissues via paramagnetic effects, leading to enhanced signal intensity in MRI images.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Imaging Enhancement.